Skip to main content

Discover

Today
Discover
Macro & World
Company News
Factor Rankings
Screener
Compare

Markets

Heatmap
Gainers & Losers

Calendars

Earnings
This Week
Macro
PDUFA (Biotech)

Portfolio

Portfolio Tracker
Portfolio Lab

SEC & Filings

Watchlist Filings
Super InvestorsNEW
What Big-Tech OwnsNEW

Premium Reports

Weekly Market LetterNEW
NotificationsNEW

Community

Saved Articles
Community
Invite FriendsFREE

Account

Pricing
Settings
Help

Stonvex

Loading…

Home Markets Screener Portfolio Community

Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

← Back to rankings

IMA

Live

Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News

A data-driven market analytics platform for US equities.

stonvexceo@gmail.com

Product

Rankings
Factor Rankings
Screener
Markets
Calendar
News Impact
Sample AI Reports

Company

About Stonvex
Pricing & Plans
Methodology
Community
Help & FAQ
Contact Us
Invite Friends

Legal

Terms of Service
Privacy Policy
Refund Policy
Privacy Consent
Disclaimer
Notices & Updates

Stonvex205-1307 66, Jungbu-daero 223beon-gil, Paldal-gu, Suwon-si, Gyeonggi-do, Republic of Koreastonvexceo@gmail.com

Risk warning

Investing in equities carries significant risk, including the potential loss of your entire investment. Volatility, liquidity, geopolitical, and currency risks can all materially affect outcomes. Past performance does not guarantee future results. Nothing on Stonvex is investment advice, a recommendation, or a solicitation to buy or sell any security. Stonvex is not a registered investment advisor (RIA), broker-dealer, or financial planner. You should consult a licensed advisor before making investment decisions and only invest capital you can afford to lose.

© 2026 Stonvex. All rights reserved.

Service not available to residents of: Belarus, China, Cuba, France, Germany, India, Iran, Japan, North Korea, Russia, South Korea, Sudan, Syria. See Terms. You must be 18 years or older to use this service.

Log in Get Started

Loading latest news…

☁️ News word cloud

Top words across the last 50 articles for this ticker.

ox40targetedclinicaltrials

52w low +47.0%

IMAImageneBio, Inc. Common Stock